Dexmedetomidine (DEX), a centrally acting alpha‐2 agonist, is increasingly used for sedation in multiple clinical settings. Evidence from the intensive care unit and operative settings suggests DEX may have significant… Click to show full abstract
Dexmedetomidine (DEX), a centrally acting alpha‐2 agonist, is increasingly used for sedation in multiple clinical settings. Evidence from the intensive care unit and operative settings suggests DEX may have significant advantages over traditional GABAergic sedatives such as benzodiazepines. There has been limited research on the use of DEX in the emergency department (ED).
               
Click one of the above tabs to view related content.